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Does Sphincteroplasty Predispose to Bile Duct Cancer?
ABSTRACT
Hakamada, K., Sasaki, M., Endoh, M., Itoh, T., Morita, T.
and Konn, M. (1998) Late development of bile duct cancer
after sphincteroplasty: A ten- to twenty-two-year follow-up
study. Surgery; 121, 488-492.
Background: Transduodenal sphincteroplasty is de-
signed to destroy the sphincteric muscle fibers,
producing a terminal choledochoduodenostomy. In
the absence of Oddi’s sphincter, intestinal contents
with both activated pancreatic juice and bacterial
flora are refluxed into the bile duct and remain
there for a prolonged time. The long-term effect
of producing the reflux has not been evaluated to
date.
Methods: One hundred nineteen consecutive pa-
tients undergoing transduodenal sphincteroplasty
between February 1973 and July 1984 were included
in this study. Postoperative clinical courses of 108
patients could be evaluated by means of a retro-
spective review of the hospital records. Median
follow-up was 18 years.
Results: Eight cases (7.4%) of primary bile duct
cancer were found among the 108 cases at intervals
of 1 to 20 years after sphincteroplasty. Two patients
has concurrent hepatolithiasis. The patency of
sphincteroplasty was confirmed in all cases, and
the bile was infected in seven cases. Pathologic
specimens obtained demonstrated cholangiocarcino-
mas and various degrees of atypical hyperplastic
lesions under the background of chronic cholangitis.
Conclusions: Chronic cholangitis can be an impor-
tant causative factor in late development of bile duct
cancer after sphincteroplasty. Any patients treated
with choledochoduodenostomy should be closely
monitored for late cholangiocarcinoma. (Surgery,
1997; 121: 488-492).HPB INTERNATIONAL 205
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PAPER DISCUSSION
The report by Hakamada and colleagues is
interesting, and on first perusal, raises a poten-
tially disturbing message. They reviewed 119
consecutive patients on whom a transduodenal
sphincteroplasty had been performed more than
10 years before and were able to evaluate 108 of
the patients by means of a retrospective review
of hospital records. They found eight patients
who developed cholangiocarcinoma at intervals
of one to 20 years following sphincteroplasty.
Four of the patients were diagnosed less than 10
years and four during the second decade after
sphincteroplasty: They confirmed the patency of
the sphincteroplasty in all cases and, in addition
to cholangi0carcioma, demonstrated various
degrees of hyperplastic lesions and atypia of
the biliary epithelium. They showed infected
bile from samples obtained by direct puncture of
the intrahepatic bile duct adjacent to the tumour
in seven of the eight patients. They concluded
that the absence of the sphincter mechanism
allowed intestinal contents, with activated pan-
creatic juice and bacterial flora, to reflux into the
biliary tree and that chronic cholangitis ensued
and this was an important causative factor in the
late development of bile duct cancer. At first site,
this seems a plausible hypothesis.
Two of the patients would appear to have had
little carcinogenic predisposition- acalculous
cholecystitis and chronic pancreatitis and devel-
oped carcinoma 20 and 18 years respectively
after surgery. One patient had gall bladder
stones as well as choledocholithiasis while the
others had choledocholithiasis with one diag-
nosed as hepatolithiasis. It is difficult for the
reviewer to determine whether these cases were
variants of hepatolithiasis or whether these were
secondary stones. Cholangiocarcinoma is a well
known complication of hepatolithiasis, even
after apparent, complete removal of all calculi
[1].
The diagnosis of carcinoma was made one
year after sphincteroplasty in one patient and it
would have to be concluded that this was
present at the time of operation, albeit undiag-
nosed. The two patients whose malignancy was
diagnosed at five years, presumably had pre-
cancerous changes or carcinoma in-situ which
may have been accelerated by the procedure. It
would not be surprising that bile culture from
obstructed ducts proximal to the carcinoma
would be infected. This could well be effect,
rather than cause, although it is conceded that
culture of bile from the biliary tree is likely to
contain bacteria after any biliary-enteric ana-
stomosis.
There is some experimental evidence that
would support the hypothesis that biliary-
enteric anastomosis is a carcinogenic proce-
dure[2,3]. If transduodenal sphincteroplasty
does make the patient susceptible to the devel-
opment of cholangiocarcinoma, it would be
expected that with all the choledochoduodenos-
tomies and sphincteroplasties (the latter could
be regarded as an internal choledocho-duode-
nostomy) performed in the past, there would be
numerous reports of late cholangiocarcinoma.
The reviewer is aware of only three reports of
late cholangiocarcinoma following biliary-en-
teric anastomosis for benign disease [4-6] and
has personal experience of three cases. It is
possible that the condition has been under-
reported. No increased risk of bile duct cancer
was found in patients who underwent choledo-
choduodenostomy or sphincterotomy, combined
with cholecystectomy in the report by Ekbom
et al. [7]. Nor was their any increased risk of
cancer following sphincterotomy for stones in
the common bile duct in a population based
study from Sweden [8]. It could be argued that
destruction of the Sphincter of Oddi by endo-
scopic sphincterotomy is less likely to lead to
reflux of duodenal contents as does formal
sphincteroplasty but this has not been tested.206 HPB INTERNATIONAL
Does sphincteroplasty or any other biliary-
enteric anastomotic procedure predispose to bile
duct cancer? There is some evidence to support
the hypothesis but the jury is still out. The report
by Hakamada may prompt review by other
investigators and place the risk of developing
cholangiocarcinoma after biliary-enteric ana-
stomosis in its true perspective.
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